Objectives The third EUROASPIRE survey included people at high cardiovascular risk in general practice. The aim was to determine whether the Joint. Aim The aim of the European Action on Secondary and Primary Prevention by Intervention to Reduce Events III (EUROASPIRE III) survey was to determine. These are the results of the primary-prevention EUROASPIRE III study, a survey of 12 participating countries that was designed to assess.

Author: Samushakar Terg
Country: Malta
Language: English (Spanish)
Genre: Health and Food
Published (Last): 15 January 2015
Pages: 19
PDF File Size: 13.33 Mb
ePub File Size: 9.12 Mb
ISBN: 765-2-34707-580-9
Downloads: 8537
Price: Free* [*Free Regsitration Required]
Uploader: Mezisida

Citations Publications citing this paper.

Comorbidity complicates cardiovascular treatment: Predictors of cardiac rehabilitation referral in coronary artery disease patients. Factors affecting cardiac rehabilitation referral by physician specialty.

EuroAspire III

The therapeutic control of euroaspure is poor. We defined risk factors as unmodifiable risk factors: Global and regional burden furoaspire disease and risk factors, This nurse-led multidisciplinary programme significantly improved the management of lifestyle and medical risk factors for cardiovascular disease prevention in coronary patients and patients at high multifactorial risk for developing heart disease.

Circulation 22; The prevalence of smoking was virtually unchanged over the three surveys with about one in five patients still smoking at the time of interview. We wanted to find out to what extent physicians refer to rehabilitation patients following cardiac events revascularization procedures, acute myocardial infarction and acute ischemia without revascularization procedure ; which are the participation rates and general profile of patients who participated in CR programs offered by Cardiovascular Rehabilitation Clinic in Timisoara; what are their main outcomes in regard to risk factors control after furoaspire mean period of 16 months following the cardiac event.

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: Eur J Cardio Prev Rehab WHO definition The World Health Organization WHO defined CR in in a euroaspirw way that is lii and sensitive to the psychosocial, biomedical, professional expertise and service delivery mode and location elements required of a contemporary CR service.

  APUESTA POR TI WALTER DRESEL PDF

Cardiac rehabilitation coordinators’ perceptions of patient-related barriers to implementing cardiac evidence-based guidelines. Mean values decreased at 16 months for diastolic blood pressure from Exercise-based rehabilitation for coronary heart disease.

Results from a physician survey in Germany. Prevalence of dyslipidemia in statin-treated patients in the Baltic states Estonia, Latvia, and Lithuania: Timisoara was the only center in Romania that participated in EuroAspire survey. The two most recent surveys included for the first time individuals free from any manifestations of but at high risk of developing CVD because of arterial hypertension, dyslipidemia or type 2 diabetes. General characteristics in the 3 groups at baseline T1.

iki

[EUROASPIRE III: a comparison between Turkey and Europe]. – Abstract – Europe PMC

What is required is a comprehensive risk reduction approach to lifestyle, risk factor and therapeutic management to reduce total cardiovascular risk. Timisoara Medical Scientific Association.

Cochraine Database Syst Rev ; l: In the primary care arm, the gap between evidence based guidelines and clinical practice was even greater than that seen for coronary patients 18 European guidelines on cardiovascular disease prevention in clinical practice: The risk of future CVD can be further reduced by optimizing the prescription of cardioprotective medication, combining different drugs and up-titrating them to the euroaslire showing efficacy and safety in clinical trials.

Based on their participation in rehabilitation, we split the whole lot into 3 groups: The use of cardioprotective medication was as follows: Congenital Heart Disease and Pediatric Cardiology.

Simvastatin Search for additional papers on this topic. We evaluated life style trends and cardiovascular risk factors management using questionnaire method, measuring anthropometric and hemodinamic parameters and performing blood tests. However, there was a two-fold increase in the proportion of patients on high intensity statins between the III and IV surveys. Pentru evaluarea pacientilor am folosit metoda chestionarului, am masurat parametrii antropometrici si hemodinamici si am recoltat analize de sange.

  CABECITA NEGRA DE GERMAN ROZENMACHER PDF

The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention

February Br J Cardiol ; Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: You are not logged in You need to be a member to print this page. Adina Avram, 1 Baba Dochia Str. Only total cholesterol reduction was statistically significant.

EuroAspire II enrolled consecutive coronary patients from 47 centres in 15 countries at about 1. EuroAspire I and II surveys both showed a high prevalence of unhealthy lifestyles, modifiable risk factors and inadequate use of drug therapies to reach risk factors goals in patients with established coronary heart disease CHD. The lab tests performed were: The effects of phase II of cardiovascular rehabilitation on lipids and lipoproteins in diabetic patients with and without cardiovascular disease.

J Am Coll Cardiol ; All coronary and high CVD risk people require a comprehensive preventive cardiology programme, combining a professional lifestyle intervention with euroasire risk factor ili to achieve better risk factor control and adherence with cardioprotective medications, and to reduce the risk of future cardiovascular events.

Trebuie sa identificam cauzele care limiteaza accesul pacientilor coronarieni, fie ca tin de medic, pacient sau de alti factori externi si sa actionam corectiv asupra lor, in scopul cresterii standardului ingrijirii medicale.